Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Completed
- Conditions
- Alzheimer's Disease
- Registration Number
- NCT00698165
- Lead Sponsor
- AstraZeneca
- Brief Summary
Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2400
Inclusion Criteria
- Clinical diagnosis of possible or probable Alzheimer's disease, with or without vascular elements
- The primary caregiver can be identified
- The patient and his/her primary caregiver are both willing and able to participate in the study
Read More
Exclusion Criteria
- Patient or caregiver affected by alcohol or narcotics to the extent that it interferes with the completion of the study
- Patient or caregiver does not understand English
- Patient and/ or caregiver is the physician or physician's staff
- Patient and/ or caregiver is a family member of the physician or physician's staff
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mini-Mental State Examination (MMSE), Disability Assessment for Dementia Scale (DAD), Neuropsychiatric Inventory Questionnaire (NPI-Q) Collected one time only
- Secondary Outcome Measures
Name Time Method Resource Utilization in Dementia (RUD) collected one time only Short Form - 12 domains instrument (SF-12) collected one time only World Health Organization Quality of Life instrument (WHO-QoL) collected one time only Zarit Caregiver Burden Interview (ZBI) collected one time only 15 domains Quality of Life Index instrument (15D) collected one time only
Trial Locations
- Locations (1)
Research Site
🇬🇧Uckfield, United Kingdom